PL336265A1 - 5,6,7-trisubstituted-4-aminopyrido[2,3-d]pyrimidine compounds - Google Patents

5,6,7-trisubstituted-4-aminopyrido[2,3-d]pyrimidine compounds

Info

Publication number
PL336265A1
PL336265A1 PL98336265A PL33626598A PL336265A1 PL 336265 A1 PL336265 A1 PL 336265A1 PL 98336265 A PL98336265 A PL 98336265A PL 33626598 A PL33626598 A PL 33626598A PL 336265 A1 PL336265 A1 PL 336265A1
Authority
PL
Poland
Prior art keywords
aminopyrido
trisubstituted
pyrimidine compounds
pyrimidine
compounds
Prior art date
Application number
PL98336265A
Other languages
English (en)
Inventor
Shripad S Bhagwat
Richard J Perner
Yu Gui Gu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PL336265A1 publication Critical patent/PL336265A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL98336265A 1997-04-16 1998-04-13 5,6,7-trisubstituted-4-aminopyrido[2,3-d]pyrimidine compounds PL336265A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84348497A 1997-04-16 1997-04-16
PCT/US1998/007201 WO1998046604A1 (en) 1997-04-16 1998-04-13 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds

Publications (1)

Publication Number Publication Date
PL336265A1 true PL336265A1 (en) 2000-06-19

Family

ID=25290123

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98336265A PL336265A1 (en) 1997-04-16 1998-04-13 5,6,7-trisubstituted-4-aminopyrido[2,3-d]pyrimidine compounds

Country Status (19)

Country Link
EP (1) EP0975633A1 (xx)
JP (1) JP2001520654A (xx)
KR (1) KR20010006462A (xx)
CN (1) CN1252069A (xx)
AR (1) AR012437A1 (xx)
AU (1) AU741033B2 (xx)
BG (1) BG103853A (xx)
BR (1) BR9809056A (xx)
CA (1) CA2286592A1 (xx)
CO (1) CO4940470A1 (xx)
HU (1) HUP0001443A3 (xx)
IL (1) IL131617A0 (xx)
NO (1) NO995035L (xx)
NZ (1) NZ337125A (xx)
PL (1) PL336265A1 (xx)
SK (1) SK140099A3 (xx)
TR (1) TR199902550T2 (xx)
WO (1) WO1998046604A1 (xx)
ZA (1) ZA983175B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057040A1 (en) * 2000-02-03 2001-08-09 Abbott Laboratories 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
IL156872A0 (en) 2001-02-12 2004-02-08 Hoffmann La Roche 6-substituted pyrido-pyrimidines
CN107744520A (zh) * 2017-10-25 2018-03-02 南京多宝生物科技有限公司 嘧啶类化合物在制备促进小肠蠕动药物中的应用
CN112209924B (zh) * 2019-07-09 2022-04-05 中国科学院天津工业生物技术研究所 选择性腺苷a1受体拮抗剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB774094A (en) * 1953-01-02 1957-05-08 Wellcome Found Improvements in or relating to pyrimidine compounds
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds

Also Published As

Publication number Publication date
KR20010006462A (ko) 2001-01-26
SK140099A3 (en) 2000-05-16
JP2001520654A (ja) 2001-10-30
ZA983175B (en) 1998-10-21
AU7108098A (en) 1998-11-11
HUP0001443A2 (hu) 2000-10-28
NZ337125A (en) 2001-06-29
WO1998046604A1 (en) 1998-10-22
CN1252069A (zh) 2000-05-03
CA2286592A1 (en) 1998-10-22
AR012437A1 (es) 2000-10-18
TR199902550T2 (xx) 2000-04-21
HUP0001443A3 (en) 2001-01-29
NO995035D0 (no) 1999-10-15
AU741033B2 (en) 2001-11-22
BR9809056A (pt) 2000-08-01
CO4940470A1 (es) 2000-07-24
NO995035L (no) 1999-12-15
BG103853A (en) 2000-06-30
IL131617A0 (en) 2001-01-28
EP0975633A1 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
IL139598A0 (en) PYRROLO [2,3-d] PYRIMIDINE COMPOUNDS
AP9901584A0 (en) Pyrrolo[2,3-d] pyrimidine compounds
EG24399A (en) Pyrrolo[2,3-D]pyrimidine compounds
IL125358A0 (en) 5H-thiazolo [3,2-a] pyrimidine derivatives
HK1069577A1 (en) Pyrazolo [4,3-D] pyrimidine derivatives
AU1794697A (en) 7-alkyl-pyrrolo{2,3-d}pyrimidines
PL353366A1 (en) Pyrazolo[4,3-d]pyrimidines
ZA983177B (en) 5,7-Disubstituted-4-aminopyrdo [2,3] pyrimidine compounds
GB9506309D0 (en) Pyrimidine compounds
IL136500A0 (en) 1,4-diazacycloheptane derivatives
IL131892A0 (en) 6, 7-Disubstituted-4-aminopyrido [2, 3-d] pyrimidine compounds
PL336265A1 (en) 5,6,7-trisubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
EP0904271A4 (en) 5,6,7,8-tetrahydropyrido [2,3-d] PYRIMIDINE
ZA994004B (en) Pyrrolo[2,3-d]pyrimidine compounds.
SI1087970T1 (en) PYRROLO 2,3-d)PYRIMIDINE COMPOUNDS
GB2316077B (en) Pyrimidine Compounds
AU3500997A (en) 5,6,7,8-tetrahydropyrido{2,3-d}pyrimidine derivatives
SI1210349T1 (en) PYRAZOLO 4,3-d)PYRIMIDINES
EP0954316A4 (en) PYRIMIDINE DERIVATIVES